Remove 2022 Remove Healthcare Remove Medical science
article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals.

article thumbnail

2022 Pharma Marketing Trend to Watch: Musical Chairs

Eversana Intouch

Welcome to 2022! More bleakly, according to estimates from the WHO and The Guardian /Kaiser Health News, by the spring of 2021, more than 100,000 healthcare workers globally had died from COVID-19, and more than 3,600 of those were in the United States.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

There, Boehringer had earlier warned of the impending alteplase shortage in April 2022. As a result, healthcare providers need to rely on generic manufacturers, but there are only a few who make them, he explains. Authorities from individual EU member states, like those from Czechia, have shared their individual warnings.

Medicine 111
article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].

article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Seamless data sharing between clinical teams and medical science liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement.

Marketing 105
article thumbnail

Biologic Prices Decreasing As More Commercial Health Plans Allow Biosimilars as First-Line Options

PM360

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.

article thumbnail

Pharmaceutical Companies Also Made the Fortune 500 List

Medico Reach

billion by 2022. They aim to transform healthcare and create a healthier world. It developed the COVID vaccine Comirnaty and received FDA approval for TicoVac and Prevnar 20. Famous for developing baby care products, they are committed to offering healthcare services to all stages of life. Invention Ranking : 1.